Senescence and immortality in hepatocellular carcinoma. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Cancer Letters Year : 2009

Senescence and immortality in hepatocellular carcinoma.


Cellular senescence is a process leading to terminal growth arrest with characteristic morphological features. This process is mediated by telomere-dependent, oncogene-induced and ROS-induced pathways, but persistent DNA damage is the most common cause. Senescence arrest is mediated by p16(INK4a)- and p21(Cip1)-dependent pathways both leading to retinoblastoma protein (pRb) activation. p53 plays a relay role between DNA damage sensing and p21(Cip1) activation. pRb arrests the cell cycle by recruiting proliferation genes to facultative heterochromatin for permanent silencing. Replicative senescence that occurs in hepatocytes in culture and in liver cirrhosis is associated with lack of telomerase activity and results in telomere shortening. Hepatocellular carcinoma (HCC) cells display inactivating mutations of p53 and epigenetic silencing of p16(INK4a). Moreover, they re-express telomerase reverse transcriptase required for telomere maintenance. Thus, senescence bypass and cellular immortality is likely to contribute significantly to HCC development. Oncogene-induced senescence in premalignant lesions and reversible immortality of cancer cells including HCC offer new potentials for tumor prevention and treatment.



Dates and versions

inserm-00357544 , version 1 (30-01-2009)



Mehmet Ozturk, Ayca Arslan-Ergul, Sevgi Bagislar, Serif Senturk, Haluk Yuzugullu. Senescence and immortality in hepatocellular carcinoma.. Cancer Letters, 2009, 286 (1), pp.103-13. ⟨10.1016/j.canlet.2008.10.048⟩. ⟨inserm-00357544⟩
146 View
0 Download



Gmail Facebook X LinkedIn More